iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Subjects:

Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Subjects:

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 1. by Rahsan Erdem (11726357)

Subjects:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 2. by Rahsan Erdem (11726357)

Subjects:

Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 3. by Rahsan Erdem (11726357)

Subjects:

Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

Subjects:

Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Flow diagram of this study. by Jae-Chan Ryu (2850581)

“…The risk of in-stent restenosis of more than 50% was significantly decreased when TC/HDL-C ratio (odds ratio [OR] 0.22, [95% confidence interval (CI) 0.05–0.87]) and LDL-C/HDL-C ratio (OR 0.23, [95% CI 0.06–0.93]) decreased or when HDL-C levels (OR 0.10, [95% CI 0.02–0.63]) were increased at 12 months compared with baseline measurements.…”

Minimum inhibitory concentration of vancomycin, sulfamethoxazole-trimethoprim, oxacillin, and linezolid after 50 cycles of propagation. by Samuel E. Blechman (19506884)

The percentage of tPSA levels over 20 ng/mL in PCa patients. by Rong Na (297455)

“…<p>There was a significant decrease in the percentage of tPSA levels over 20 ng/mL in PCa patients from 2003 to 2010 (<i>P_trend</i> = 2.26×10⁻⁵).…”

Chloro Half-Sandwich Osmium(II) Complexes:  Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity by Anna F. A. Peacock (1297842)

“…The rates of hydrolysis at acidic pH* decreased when the primary amine N-donors (NN = en, <i>t</i>_1/2 = 0.6 h at 318 K) are replaced with π-accepting pyridine groups (e.g., NN = phen, <i>t</i>_1/2 = 9.5 h at 318 K). …”

Chloro Half-Sandwich Osmium(II) Complexes:  Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity by Anna F. A. Peacock (1297842)

“…The rates of hydrolysis at acidic pH* decreased when the primary amine N-donors (NN = en, <i>t</i>_1/2 = 0.6 h at 318 K) are replaced with π-accepting pyridine groups (e.g., NN = phen, <i>t</i>_1/2 = 9.5 h at 318 K). …”

Chloro Half-Sandwich Osmium(II) Complexes:  Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity by Anna F. A. Peacock (1297842)

“…The rates of hydrolysis at acidic pH* decreased when the primary amine N-donors (NN = en, <i>t</i>_1/2 = 0.6 h at 318 K) are replaced with π-accepting pyridine groups (e.g., NN = phen, <i>t</i>_1/2 = 9.5 h at 318 K). …”